Universum therapeutics

Company Bio

Founders

LvlUp insightsGenerated from LvlUp’s portfolio data and the company’s own updates
Similar companies

More in the LvlUp portfolio

See all →

Building something ambitious?

LvlUp Ventures backs founders from first check to late stage.

Apply for funding
Kennedy Mwenga
Pre-Seed
United States
BioTech, HealthTech, AI, DeepTech
What we sell: Computational validation sprints - de-risked hit packages with structural rationale, selectivity profiling, resistance assessment, and ADMET predictions for conserved essential-pathway targets. Who we sell to: Pharma R&D teams, biotechs, government entities, and NGOs seeking novel mechanisms for AMR, oncology, and emerging infectious diseases. How revenue comes in: 1. Paid pilots($50-150K per indication) — 3-6 month validation sprints 2. Milestone payments — on partnered programs advancing to lead optimization 3. Royalties — on successfully developed therapeutics 4. Spinout upside — therapeutics spinout generates separate value without diluting platform investors

I'm building a cancer and infectives therapeutics platform with NSCLC and AMR as the wedge.